Skip to Main Content

Paper Details

Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mol Oncol
7
2022
DNA topoisomerase I, MBC, MBCs, Patients, RNA, TOPO1, irinotecan, metastatic breast cancer, metastatic breast cancers, patients
Author NameAffiliation
Mariaelena PierobonGeorge Mason University
David W CraigTranslational Genomics Research Institute
Lance A LiottaGeorge Mason University
John D CarptenTranslational Genomics Research Institute
Emanuel F PetricoinGeorge Mason University
Emanuel F PetricoinGeorge Mason University
  • 1 - 6

Datasets

Release 1.2